Literature DB >> 32005988

HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma.

Gabrielle Sonigo1, Maxime Battistella2, Marie Beylot-Barry3, Saskia Ingen-Housz-Oro4, Nathalie Franck5, Stéphane Barete6, Serge Boulinguez7, Olivier Dereure8, Nathalie Bonnet9, Gérard Socié10, Pauline Brice11, Olivia Boccara12, Christine Bodemer12, Henri Adamski13, Michel D'Incan14, Nicolas Ortonne15, Sylvie Fraitag16, Florence Brunet-Possenti17, Stephane Dalle18, Felipe Suarez19, Ambroise Marçais19, François Skowron20, Dima Haidar21, Eve Maubec22, Gerome Bohelay22, Liliane Laroche22, Antoine Mahé23, Elodie Birckel23, Jean-David Bouaziz1, Isabelle Brocheriou24, Romain Dubois25, Sarah Faiz26, Jehane Fadlallah27, Caroline Ram-Wolff1, Agnes Carlotti28, Guido Bens29, Brigitte Balme30, Beatrice Vergier31, Sara Laurent-Roussel32, Lydia Deschamps33, Olivier Carpentier26, Philippe Moguelet24, Genevieve Herve24, François Comoz34, François Le Gall35, Guy Leverger36, Antoine Finon29, Olivier Augereau31, Claire Bléchet37, Remy Kerdraon37, Laurence Lamant38, Emilie Tournier38, Frédéric Franck39, Valérie Costes-Martineau40, Vanessa Szablewski40, Sebastien Taix41, Isabelle Beschet42, Frédéric Guerin43, Fernando E Sepulveda43, Martine Bagot1, Genevieve de Saint Basile43, David Michonneau10, Adele de Masson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32005988     DOI： 10.1182/blood.2019003811

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Recent advances in cutaneous lymphoma-implications for current and future classifications.

Authors:  J R Goodlad; L Cerroni; S H Swerdlow
Journal:  Virchows Arch       Date:  2022-10-24       Impact factor: 4.535

2.  Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations.

Authors:  Jiwon Koh; Insoon Jang; Seungchan Mun; Cheol Lee; Hee Jeong Cha; Young Ha Oh; Jin-Man Kim; Jae Ho Han; Jin Ho Paik; Junhun Cho; Young Hyeh Ko; Chan-Sik Park; Heounjeong Go; Jooryung Huh; Kwangsoo Kim; Yoon Kyung Jeon
Journal:  Blood Adv       Date:  2021-10-26

Review 3.  Cell Versus Cytokine - Directed Therapies for Hemophagocytic Lymphohistiocytosis (HLH) in Inborn Errors of Immunity.

Authors:  Oliver Wegehaupt; Katharina Wustrau; Kai Lehmberg; Stephan Ehl
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

4.  TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1.

Authors:  Camille M Lake; Kelsey Voss; Bradly M Bauman; Katherine Pohida; Timothy Jiang; Gabriela Dveksler; Andrew L Snow
Journal:  Cell Death Dis       Date:  2021-04-14       Impact factor: 8.469

Review 5.  Novel Genetic Discoveries in Primary Immunodeficiency Disorders.

Authors:  Margaret T Redmond; Rebecca Scherzer; Benjamin T Prince
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-12       Impact factor: 10.817

6.  Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy.

Authors:  Hetong Li; Dinglong Yang; Min Hao; Hongqi Liu
Journal:  Front Genet       Date:  2022-08-23       Impact factor: 4.772

7.  A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling.

Authors:  Yang Zhang; Zhihua Wang; Guoyu Hu; Jieping Li; Yongheng Chen; Yi Jiang; Haiying Zhong; Xianling Liu; Chunhong Hu; Honglin Peng; Yunxiao Xu; Zhao Cheng; Guangsen Zhang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.